In Dr. Wang's innovate project titled, “Unlocking Immunotherapy for IDH-Mutant Gliomas by Mapping and Reprogramming the Tumour Immune Microenvironment”,  this research will study will deepen our understanding of how brain tumours create an immune environment that prevents the body’s natural defenses from recognizing and attacking cancer cells. Using these insights, the project will explore new strategies to help reopen the door to immune-based therapies and advance more effective treatment options for patients facing aggressive brain tumours.

“Our translational research program focuses on gliomas, which comprise a group of aggressive brain tumours, with the goal of understanding how the tumour’s immune environment changes over time and why immunotherapy has not yet worked for most patients. Our goal is to unlock more effective and less toxic treatments for patients and families facing this devastating disease,” highlighted Dr. Wang on the funded research program.

This research grant was made possible through the generosity of Auto|One Group. Over the past four years, Auto|One Group has donated over $300,000, making them our largest donor of record. More than a leader in the automotive industry, they are a true partner in hope. Their commitment to brain cancer research is deeply personal, shaped by the loss of Dwayne Andrews - brother and best friend of Kevin Andrews, CEO and President of Auto|One Group, to glioblastoma (GBM).